US FDA Seeks to Reconsider Decision Preventing Drug Compounders From Selling Versions of Lilly's Weight Loss, Diabetes Drugs
美國FDA尋求重新考慮阻止藥物複方藥劑師銷售莉莉的減肥和糖尿病藥品的決定
US FDA Seeks to Reconsider Decision Preventing Drug Compounders From Selling Versions of Lilly's Weight Loss, Diabetes Drugs
美國FDA尋求重新考慮阻止藥物複方藥劑師銷售莉莉的減肥和糖尿病藥品的決定
譯文內容由第三人軟體翻譯。